If you need more lookups,
subscriptions start at $34 USD/month.
Charles O'Donnell Location
Cambridge, GB
Charles O'Donnell Work
Head of Clinical Strategy and Transformation @ (May 2025 - Present)
Chief of Staff, Clinical Development @ (January 2024 - May 2025)
Chief of Staff @ (May 2022 - December 2023)
Vice President, Head of Portfolio Management @ (September 2021 - May 2022)
Director of Clinical Testing, Precision Medicine and Research Procurement at AstraZeneca @ (September 2019 - September 2021)
Early Clinical Development Portfolio Director @ (September 2016 - October 2019)
Alliance Management Director @ (December 2014 - September 2016)
Head of Drug Safety and Metabolism Externalisation @ (July 2012 - December 2014)
DMPK Associate Director @ (March 2011 - July 2012)
Team Leader @ (December 2006 - March 2011)
Senior Scientist @ (January 2003 - December 2006)
Charles O'Donnell Education
University of Liverpool
PhD (Drug Metabolism)
1999-2002
University of Liverpool
BSc. (Hons) (Pharmacology)
1996-1999
Birkenhead School 1989-1996
Charles O'Donnell Skills
Drug Discovery
In Vitro
DMPK
Drug Metabolism
Pharmacokinetics
Drug Design
ADME
R&D
Regulatory Submissions
Pharmaceutical Industry
Drug Development
Toxicology
Matrix Management
Screening
Line Management
Pharmacodynamics
Lead Optimization
Preclinical Safety
Resource Management
Public Speaking
Sales
Microsoft Office
Marketing
Change Management
Project Management
Outsourcing
Charles O'Donnell Summary
Charles O'Donnell, based in Cambridge, GB, is currently a Head of Clinical Strategy and Transformation at Allergan Aesthetics, an AbbVie Company. Charles O'Donnell brings experience from previous roles at Allergan Aesthetics, an AbbVie Company, Exscientia and AstraZeneca. Charles O'Donnell holds a 1999 - 2002 PhD in Drug Metabolism @ University of Liverpool. With a robust skill set that includes Drug Discovery, In Vitro, DMPK, Drug Metabolism, Pharmacokinetics and more. Charles O'Donnell has 1 emails on RocketReach.
Looking for a different Charles O'Donnell?
Find contact details for 700 million professionals.